Covestor LTD Gilead Sciences, Inc. Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Covestor LTD holds 2,338 shares of GILD stock, worth $219,655. This represents 0.12% of its overall portfolio holdings.

Number of Shares

2,338

Previous 4,890 52.19%

Holding current value

$219,655

Previous $336,000 41.67%

% of portfolio

0.12%

Previous 0.22%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$66.59 - $83.99 $169,937 - $214,342	-2,552 Reduced 52.19%	2,338 $196,000
Q2 2024 Aug 09, 2024	BUY	$63.15 - $72.88 $105,144 - $121,345	1,665 Added 51.63%	4,890 $336,000
Q1 2024 May 10, 2024	BUY	$71.58 - $87.29 $39,583 - $48,271	553 Added 20.7%	3,225 $236,000
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $102,431 - $116,159	-1,398 Reduced 34.35%	2,672 $216,000
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $49,170 - $53,645	665 Added 19.53%	4,070 $305,000
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $49,254 - $56,181	648 Added 23.5%	3,405 $263,000
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $25,434 - $28,978	-329 Reduced 10.66%	2,757 $229,000
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $41,131 - $59,050	-660 Reduced 17.62%	3,086 $264,000
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $66,625 - $76,103	-1,119 Reduced 23.0%	3,746 $231,000
Q2 2022 Aug 10, 2022	SELL	$57.72 - $65.01 $7,445 - $8,386	-129 Reduced 2.58%	4,865 $301,000
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $156,268 - $195,820	2,698 Added 117.51%	4,994 $297,000
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $148,964 - $169,077	2,296 New	2,296 $167,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account